Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome

Human Reproduction

Volumn 13, Issue 9, 1998, Pages 2406-2410

  Fábregues, Francisco ^a   Balasch, Juan ^a,b   Manau, Dolors ^a   Jiménez, Wiadimiro ^a   Arroyo, Vicente ^a   Creus, Montserrat ^a   Rivera, Francisca ^a   Vanrell, Juan A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Haematocrit; Leukocytosis; Ovarian hyperstimulation syndrome; Platelets; Renin aldosterone system

Indexed keywords

ALDOSTERONE; NORADRENALIN; RENIN; VASOPRESSIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HUMAN; HYPOTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NORADRENALIN BLOOD LEVEL; OLIGURIA; OVARY DISEASE; PLASMA RENIN ACTIVITY; TACHYCARDIA; THROMBOCYTE COUNT; VASOPRESSIN BLOOD LEVEL;

EID: 0031659728     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.9.2406     Document Type: Article

References (27)

1. Abramov, Y., Schenker, J.G., Lewin, A. et al. (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum. Reprod., 11, 1381-1386.
2. Aurousseau, M.H., Samama, M.M., Belhassen, A. et al. (1995) Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum. Reprod., 10, 94-97.
3. Balasch, J., Arroyo, V., Carmona, F. et al. (1991) Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fertil. Steril., 56, 1077-1083.
4. Balasch, J., Arroyo, V., Fábregues, F. et al. (1994) Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann. Intern. Med., 121, 27-33.
5. Balasch, J., Arroyo, V., Fábregues, F. et al. (1995) Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. Fertil. Steril., 64, 65-68.
6. Balasch, J., Fábregues, F., Arroyo, V. et al. (1996a) Treatment of severe ovarina hyperstimulation syndrome by a conservative medical approach. Acta Obstet. Gynecol. Scand., 75, 662-667.
7. Balasch, J., Reverter, J.C., Fábregues, F. et al. (1996b) Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 608-613.
8. Bergh, P.A. and Navot, D. (1992) Ovarian hyperstimulation syndrome: a review of pathophysiology. J. Assist. Reprod. Genet., 9, 429-438.
9. Burstein, S.A. and Harker, L.A. (1983) Control of platelet production. Clin. Haematol., 17, 1038-1043.
10. Dhabhar, F.S., Miller, A.H., McEwen, B.S. and Spencer, R.L. (1996) Stress-induced changes in blood leukocyte distribution. J. Immunol., 157, 1638-1644.
11. Dinarello, C.A., Gelfand, J.A. and Wolff, S.M. (1993) Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. J. Am. Med. Assoc., 269, 1829-1835.
12. Dourron, N.E. and Williams, D.B. (1996) Prevention and treatment of ovarian hyperstimulation syndrome. Sem. Reprod. Endocrinol., 14, 355-365.
13. Elchalal, U. and Schenker, J.G. (1997) The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum. Reprod., 12, 1129-1137.
14. Golan, A., Ron-El, R., Herman, A. et al. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
15. Hock, D.L., Huhn, R.D. and Kemmann, E. (1997) Leukocytosis in response to exogenous gonadotrophin stimulation. Hum. Reprod., 12, 2143-2146.
16. Hollen, C.W., Henthorn, J., Koziol, J.A. and Burstein, S.A. (1991) Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br. J. Haematol., 79, 286-290.
17. Kodama, H., Fukuda, J., Karube, H. et al. (1995) Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil. Steril., 64, 1207-1209.
18. Lancet (1991) Ovarian hyperstimutation syndrome. [Editorial] Lancet, 338, 1111-1112.
19. Loret de Mola, J.R., Flores, J.P., Baumgardner, G.P. et al. (1996a) Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin-6 signal. Obstet. Gynecol., 87, 581-587.
20. Loret de Mola, J.R., Baumgardner, G.P., Goldfarb, J.M. and Friedlander, M.A. (1996b) Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumor necrosis factor-α cannot predict its occurrence. Hum. Reprod., 11, 1377-1380.
21. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
22. Navot, D., Bergh, P.A. and Laufer, N. (1996) The ovarian hyperstimulation syndrome. In Adashi, E. Y., Rock, J. A. and Rosenwaks, Z. (eds), Reproductive Endocrinology, Surgery, and Technology. Vol. 2. Lippincott-Raven, Philadelphia, USA, pp. 2215-2232.
23. Pride, S.M., James, C.S.J and Yuen, B.H. (1990) The ovarian hyperstimulation syndrome. Semin. Reprod. Endocrinol., 8, 247-260.
24. Quesenberry, P.J. (1995) Hematopoietic stem cells, progenitor cells, and cytokines. In Beurler, E., Lichtman, M.A., Coller, B.S. and Kipps, T.J. (eds), Williams' Hematology. 5th edn. McGraw-Hill, New York, USA, pp. 211-218.
25. Rizk, B. and Aboulghar, M. (1991) Modern management of ovarian hyperstimulation syndrome. Hum. Reprod., 6, 1082-1087.
26. Rizk, B., Aboulghar, M., Smitz, J. and Ron-El, R. (1997) The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum. Reprod. Update, 3, 255-266.
27. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.